The expression of vascular endothelial growth factor B (VEGFB) and angiopoietin 1 (ANGPT1), two pro-angiogenic factors was also increased in the Ob-NAFLD group by 38% and 41%, respectively. The gene discussed is VEGFB; the disease is metabolic dysfunction-associated steatotic liver disease.